Correlation Between Dyadic International and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyadic International and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and TC BioPharm Holdings, you can compare the effects of market volatilities on Dyadic International and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and TC BioPharm.

Diversification Opportunities for Dyadic International and TC BioPharm

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dyadic and TCBP is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Dyadic International i.e., Dyadic International and TC BioPharm go up and down completely randomly.

Pair Corralation between Dyadic International and TC BioPharm

Given the investment horizon of 90 days Dyadic International is expected to generate 0.36 times more return on investment than TC BioPharm. However, Dyadic International is 2.78 times less risky than TC BioPharm. It trades about -0.08 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.34 per unit of risk. If you would invest  177.00  in Dyadic International on December 25, 2024 and sell it today you would lose (40.00) from holding Dyadic International or give up 22.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dyadic International  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
Dyadic International 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyadic International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
TC BioPharm Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Dyadic International and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyadic International and TC BioPharm

The main advantage of trading using opposite Dyadic International and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Dyadic International and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities